Schonfeld Strategic Advisors LLC Neu Base Therapeutics, Inc. Call Options Transaction History

Schonfeld Strategic Advisors LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	BUY	$1.26 - $2.95 $16,019 - $37,506	12,714 New	12,714 $0
Q4 2021 Feb 14, 2022	SELL	$2.6 - $4.18 $33,056 - $53,144	-12,714 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$3.27 - $4.76 $41,574 - $60,518	12,714 New	12,714 $0

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.